Who
Andrew David Levin
Director
Company insider
Files Form 4 as: Director, Vor Biopharma; Executive Chairman, Climb Bio.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 9 Aug 2021
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | VOR Vor Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,162 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | VOR Vor Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,162 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | CLYM Climb Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | CLYM Climb Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 18 Dec 2025filed 19 Dec 2025 | VOR Vor Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 4 Jun 2025filed 5 Jun 2025 | CLYM Climb Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 26 Jun 2024filed 28 Jun 2024 | CLYM Climb Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | CLYM Climb Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 19 May 2022filed 1 Jun 2022 | CLYM Climb Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 9 Aug 2021filed 11 Aug 2021 | CLYM Climb Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.